Recent work has developed solid drug nanoparticles (SDNs) of efavirenz that have been demonstrated, preclinically, improved oral bioavailability and the potential to enable up to a 50% dose reduction, and is c...
from Most Recent Articles: Journal of Nanobiotechnology http://ift.tt/2IqH1u0
via IFTTT
No comments:
Post a Comment